Financials SoftMedx Healthcare Limited
Equities
648
HK0000375797
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.38 HKD | -.--% | -.--% | -.--% |
Apr. 25 | SoftMedx Healthcare Returns to Profit in 2023 | MT |
Mar. 27 | SoftMedx Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 123.9 | 123.9 | 123.9 | 123.9 | 123.9 | 123.9 |
Enterprise Value (EV) 1 | 292.3 | 348.6 | 373 | 386.7 | 396.1 | 406.3 |
P/E ratio | -1.87 x | -1.61 x | -2.44 x | -4.72 x | -6.44 x | 9.9 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.13 x | 3.09 x | 12.9 x | 72.9 x | 3.67 x | 2.41 x |
EV / Revenue | 5.02 x | 8.68 x | 38.8 x | 228 x | 11.7 x | 7.91 x |
EV / EBITDA | -5.84 x | -8.26 x | -11.8 x | -18.6 x | -44.2 x | 64.9 x |
EV / FCF | 69.5 x | -26.1 x | -37.3 x | -16.8 x | -74 x | -21.9 x |
FCF Yield | 1.44% | -3.83% | -2.68% | -5.96% | -1.35% | -4.56% |
Price to Book | -1.68 x | -0.52 x | -0.43 x | -0.39 x | -0.37 x | -0.38 x |
Nbr of stocks (in thousands) | 326,037 | 326,037 | 326,037 | 326,037 | 326,037 | 326,037 |
Reference price 2 | 0.3800 | 0.3800 | 0.3800 | 0.3800 | 0.3800 | 0.3800 |
Announcement Date | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 4/24/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 58.23 | 40.16 | 9.617 | 1.699 | 33.76 | 51.34 |
EBITDA 1 | -50.02 | -42.22 | -31.73 | -20.83 | -8.951 | 6.263 |
EBIT 1 | -52.64 | -43.65 | -32.18 | -21.05 | -9.284 | 6.038 |
Operating Margin | -90.4% | -108.7% | -334.65% | -1,238.79% | -27.5% | 11.76% |
Earnings before Tax (EBT) 1 | -64.77 | -79.22 | -52.47 | -24.72 | -16.63 | 14.37 |
Net income 1 | -66.08 | -76.98 | -50.85 | -26.28 | -19.22 | 12.51 |
Net margin | -113.48% | -191.71% | -528.71% | -1,546.5% | -56.94% | 24.37% |
EPS 2 | -0.2027 | -0.2361 | -0.1560 | -0.0806 | -0.0590 | 0.0384 |
Free Cash Flow 1 | 4.208 | -13.35 | -10.01 | -23.06 | -5.355 | -18.55 |
FCF margin | 7.23% | -33.25% | -104.11% | -1,357% | -15.86% | -36.13% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 4/24/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 168 | 225 | 249 | 263 | 272 | 282 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -3.368 x | -5.321 x | -7.851 x | -12.62 x | -30.41 x | 45.09 x |
Free Cash Flow 1 | 4.21 | -13.4 | -10 | -23.1 | -5.35 | -18.5 |
ROE (net income / shareholders' equity) | 106% | 44.2% | 18.1% | 7.71% | 5.75% | -3.75% |
ROA (Net income/ Total Assets) | -13.1% | -23.4% | -58.3% | -56.7% | -26.5% | 9.35% |
Assets 1 | 504.6 | 328.6 | 87.22 | 46.35 | 72.49 | 133.8 |
Book Value Per Share 2 | -0.2300 | -0.7400 | -0.8900 | -0.9700 | -1.030 | -0.9900 |
Cash Flow per Share 2 | 0.0400 | 0.0100 | 0 | 0.0100 | 0.0100 | 0.0200 |
Capex 1 | 0.52 | 0.16 | - | 0.52 | 0.53 | - |
Capex / Sales | 0.9% | 0.41% | - | 30.84% | 1.58% | - |
Announcement Date | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 11/5/23 | 4/24/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-.--% | 15.99M | |
-24.13% | 17.58B | |
-43.22% | 2.8B | |
+18.67% | 1.88B | |
-7.25% | 1.55B | |
+34.33% | 1.34B | |
-18.78% | 936M | |
-24.92% | 859M | |
+3.53% | 818M | |
-28.39% | 600M |
- Stock Market
- Equities
- 648 Stock
- Financials SoftMedx Healthcare Limited